Compound Detail
CHEMBL312687
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(C)=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12
Basic Information
| ChEMBL ID | CHEMBL312687 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ACWNTJJUZAIOLW-BWXYOZBYSA-N |
17
Targets
30
Activities
2
Assay Types
0
PK Parameters
20
Publications
0
Known Names
Molecular Properties
498.8
MW (Da)
7.66
ALogP
3
HBA
1
HBD
63.6
PSA (Ų)
0.32
QED
1
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 20 meas. best 5.33
EC50 10 meas. best 5.35
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| NON-PROTEIN TARGET CHEMBL3879801 | EC50 | 5.35 | 5.35 | 4500.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 5.33 | 5.13 | 4650.0 | 2 |
| A549 CHEMBL392 | EC50 | 5.21 | 5.21 | 6200.0 | 1 |
| A549 CHEMBL392 | IC50 | 5.17 | 5.03 | 6700.0 | 3 |
| SW-1736 CHEMBL614773 | IC50 | 5.14 | 5.14 | 7300.0 | 1 |
| FaDu CHEMBL612250 | EC50 | 5.14 | 5.14 | 7200.0 | 1 |
| HCT-116 CHEMBL394 | IC50 | 5.02 | 5.02 | 9600.0 | 1 |
| A-431 CHEMBL614069 | IC50 | 4.97 | 4.97 | 10720.0 | 1 |
| MCF7 CHEMBL387 | EC50 | 4.96 | 4.96 | 11000.0 | 2 |
| MCF7 CHEMBL387 | IC50 | 4.96 | 4.96 | 11060.0 | 1 |
| HT-29 CHEMBL384 | IC50 | 4.79 | 4.705 | 16140.0 | 2 |
| PC-3 CHEMBL390 | IC50 | 4.77 | 4.77 | 17000.0 | 1 |
| K562 CHEMBL385 | IC50 | 4.75 | 4.735 | 18000.0 | 2 |
| A2780 CHEMBL614004 | EC50 | 4.74 | 4.74 | 18300.0 | 2 |
| A-375 CHEMBL613859 | EC50 | 4.72 | 4.72 | 19200.0 | 1 |
| A2780 CHEMBL614004 | IC50 | 4.72 | 4.72 | 18990.0 | 1 |
| H9 CHEMBL614806 | IC50 | 4.7 | 4.7 | 20000.0 | 1 |
| DLD-1 CHEMBL614285 | IC50 | 4.7 | 4.7 | 20000.0 | 1 |
| HT-29 CHEMBL384 | EC50 | 4.67 | 4.67 | 21300.0 | 1 |
| Human immunodeficiency virus 1 CHEMBL378 | EC50 | 4.6 | 4.6 | 25000.0 | 1 |
| ADMET CHEMBL612558 | IC50 | 4.24 | 4.24 | 57000.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 4.18 | 4.18 | 65500.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32956968 | 10.1016/j.ejmech.2020.112815 | Unchecked | 5 |
| 2832544 | 10.1021/np50054a031 | Unchecked | 5 |
| 2832544 | 10.1021/np50054a031 | Raji | 4 |
| 11527742 | 10.1016/s0960-894x(01)00460-7 | SK-MEL-2 | 2 |
| 20472329 | 10.1016/j.ejmech.2010.04.018 | NON-PROTEIN TARGET | 2 |
| 15270560 | 10.1021/np049938m | K562 | 2 |
| 15270560 | 10.1021/np049938m | PC-3 | 1 |
| 8176401 | 10.1021/np50104a008 | Protein kinase C epsilon type | 1 |
| 8176401 | 10.1021/np50104a008 | Protein kinase C beta type | 1 |
| 8176401 | 10.1021/np50104a008 | ADMET | 1 |
| 8176401 | 10.1021/np50104a008 | H9 | 1 |
| 8176401 | 10.1021/np50104a008 | Human immunodeficiency virus 1 | 1 |
| 15270560 | 10.1021/np049938m | CCRF-CEM | 1 |
| 15270560 | 10.1021/np049938m | HT-29 | 1 |
| 11527742 | 10.1016/s0960-894x(01)00460-7 | HCT-116 | 1 |
| 17614290 | 10.1016/j.bmc.2007.06.033 | ADMET | 1 |
| 17614290 | 10.1016/j.bmc.2007.06.033 | DLD-1 | 1 |
| 17614290 | 10.1016/j.bmc.2007.06.033 | A549 | 1 |
| 11527742 | 10.1016/s0960-894x(01)00460-7 | PC-3 | 1 |
| 11527742 | 10.1016/s0960-894x(01)00460-7 | UACC-257 | 1 |
Data from ChEMBL 36 via Core Engine